Summary of Person’s Characteristics
Selina Verardi
1. NAME OF THE PRODUCT
Invented name: Selina Verardi
Date of manufacture (MFD): approximately in 1983*
*Selina being a typical biological product with a lengthy and complex manufacturing process, the release date has been defined as the MFD.
2. QUALITATIVE UND QUANTITATIVE COMPOSITION
Active ingredient | One brain / two boxing hands per unit. |
Certificate of suitability | University of Berne / Basel (2008), MSc Pharmaceutical Sciences / Pharmacist (Swiss Federal Diploma) |
Excipients | Proteins, carbohydrates, lipids, salts and water. |
Impurities | The product may contain traces of alkaloids (caffeine) as impurities, especially around 10 a.m. |
As a consequence of her intensive sport activities, she often appears in the after shower look with freshly washed wet hair.
3. PHARMACEUTICAL FORM
Solution for test of patience. Female.
Primary and secondary packaging materials are subject to permanent change in that:
- the brown hair may be dry or wet
- secondary packaging materials (clothes) are regularly exchanged and may be either long or very short skirts and trendy shoes. Independent of the season and temperature she loves to wear strap T-shirts.
Height: Model size, with normal body mass index (high percentage of muscles).
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
Substitution or replacement therapy in:
- Situations of regulatory overload resulting in depression or nerve crisis
- Beginning or fully blown regulatory crisis with imminent cardiac arrest of company general manager
First line therapy in situations of:
- Approaching deadline for dossier submission (Switzerland, EU) without dossier on the horizon
- Pre-or post-inspectional trauma
- Upcoming IT problems with new regulatory systems
- Entering into discussions in Rhaeto - Romanic (her mother tongue)
- Updating meticulously SOPs with tons of patience.
Sociological studies demonstrate a very high efficacy and an excellent safety profile of Selina in all the above indications, particularly in the last one (therapeutic gold standard).
4.2 Posology and method of administration
Posology
The dose and dosage regimen is dependent on the indication. Typically, Selina is applied until the disease symptoms resolve. The actual dosage regimen is subject to negotiation. The regular daily dose should be in the order of magnitude of 8 hours, the weekly dose should preferentially not exceed 3 days. Higher daily or weekly doses may be agreed upon, however.
Method of administration
Selina can work either from her home office, at the clients’ premises, or at any other place according to agreements. The client is responsible for providing an appropriate working environment and a Vespa parking space if Selina is to be administered outside her home office. A good working atmosphere is highly recommended in order to warrant full efficacy.
4.3 Contraindications
Selina is absolutely contraindicated in case of hypersensitivity to chaotic brain activities of customers. She considers herself to be relatively contraindicated in case of discussion with policemen signing fines for her spontaneous parking activities of her beloved Vespa.
4.4 Special warnings and precautions for use
Sociological data reveal no special hazard for humans. Ignoring of unteachable customers or related behaviour can occur in rare cases.
4. 5 Interactions
Active surveillance indicates that interactions with Selina are strong but typically extremely benign. This claim is substantiated by customers asking repeatedly for her services.
4.6 Effects on ability to drive and use machines
WARNING: Do not give her a task which she does not consider meaningful. This might result in harsh discussions which might endanger the ability to drive or use machines.
4.7 Undesirable effects
In the majority of cases, Selina does not evoke any undesired reactions. Rarely, incompatibility reactions like rise in blood pressure, moderate to severe headache and the desire to shout at Selina may be provoked by treatment. If you experience adverse reactions, especially of a type not described in this document, please inform Selina.
Under exceedingly high doses of treatment the clients’s treasurer may simulate a heart attack when receiving her invoice.
4.8 Overdose
Overdose has not commonly been observed. There are indications, however, that prolonged exposure to Selina may lead to improved accuracy of delivered documents.
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
Selina shows strong affinity to sports (especially boxing), Italian self-cooked food (at 11 a.m.) and sunny beaches in her leisure time to recover energy. These mechanisms appear to be a conditio sine qua non for her mode of action.
5.2 Pharmacokinetic properties
After administration, Selina is immediately and completely bioavailable for the client’s projects. The distribution volume depends on the distance to office, the velocity of her Vespa and the availability of multiple computer screens.
6. PHARMACEUTICAL PARTICULARS
6.1 Incompatibilities
None observed to date. See also Special warnings and special precautions for use, however.
6.2 Shelf life and storage conditions
If the recommended dosage regimen as described under "4.2 Posology and method of administration" is followed, Selina shows no evidence of instability when kept at room temperature (20 – 25°C).
Shaking before administration is not only unnecessary but may result in a punch to your nose (with or without glove).
Do not freeze.
7. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Regulix LTD
Effingerstrasse 6a
3011 Bern
office@regulix.ch
+41 79 735 96 96
8. DATE OF REVISION OF THE TEXT
June 2025